


<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">



    
<title>Menactra (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine)</title>

    <meta property="og:site_name" content="home" />
    <meta property="og:type" content="home" />
    <meta property="og:title" content="." />
    <meta property="og:description" content="." />

    <meta name="keywords" content="Menactra,Menactra Vaccine,Meningitis in Adolescents,Meningitis,Meningococcal Vaccine,Sanofi Pasteur" />
    <meta name="description" content="п»їп»їMenactra is indicated for active immunization to prevent invasive meningococcal disease (serogroups A, C, Y, and W). US teens may be at increased risk of meningitis if they have not been vaccinated." />
<meta name="robots" content="INDEX, FOLLOW" />
<meta http-equiv="content-language" content="en" />
<meta http-equiv="content-type" content="text/html;charset=UTF-8" />
<meta http-equiv="last-modified" content="2020-06-12@00:00:00 Z" />
<meta http-equiv="X-Served-By" content="SNF-PRODNA-CD1" />
    <link rel="canonical" href="https://www.menactra.com/" />
<meta property="og:url" content="https://www.menactra.com/" />

    <script src="/Areas/GlobalComponents/js/app_insight_monitoring.js" type="text/javascript"></script>
    


    <meta name="viewport" content="initial-scale=1.0, maximum-scale=1.0, user-scalable=no" />
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-KK5VM6J');</script>
<!-- End Google Tag Manager -->




    <!-- Bootstrap core CSS -->
    
    <link rel="stylesheet" href=/Areas/GlobalComponents/css/Global/Libraries/Bootstrap/bootstrap.min.css>
    <link rel="stylesheet" href=/Areas/GlobalComponents/css/Global/Libraries/FontAwesome/all-5.4.2.min.css />
     <link href="/resources/css/site/8e6f5b54f06840e8856e18264d4053f8.css?u=20200612162718" rel="stylesheet"></link>



    <script src="/Areas/GlobalComponents/js/modernizr.min.js"></script>

    <script>        //document.cookie = ' = ' + screen.width  + '; path=/'; </script>

    
</head>
<body>
    
<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KK5VM6J"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
    <script src=/Areas/GlobalComponents/js/Global/Libraries/jQuery/jquery-3.3.1.min.js></script>
    <div class="container">
        <div  class="row one-column">        <div class="col-lg-12">
            
<div ><header id='dcv-main-nav'>
    <div class='row company-large'><a href='https://www.sanofi.us/'><img src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/sanofi-pasteur-logo.png?h=52&amp;la=en&amp;w=312&amp;hash=675D044D0BBDC7C416DE33DC1A3C2FEB0E83B1A7" alt="Sanofi Pasteur logo" width="312" height="52" /></a></div>
    <div class='row'>
        <div class='col-lg-3 col-sm-12 brand-large'><a href='/'><img src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/logo.png?h=269&amp;la=en&amp;w=589&amp;hash=7BD02259D1233F8074728710046F6706B935C7CE" alt="MenactraВ® (Groups A,C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine logo" width="589" height="269" /></a></div>
        <div class='col-lg-6 col-sm-12'>
            <ul class='utility-links-large'>
                <li><a href="#in-page-isi" class="hcpone">Important <br>Safety Information</a></li>
                <li><a href="https://www.vaccineshoppe.com/image.cfm?doc_id=12580&amp;image_type=product_pdf" class="hcptwo" target="_blank">Prescribing<br> Information</a></li>
                <li><a href="https://www.sanofiusmedicalinformation.com/" class="hcp-link" target="_blank">Medical<br> Information</a></li>
            </ul>

            
            
            
        </div>
        <div class='col-lg-3 col-sm-12 search-container-large'>
            <div class='audience'>For US Healthcare Professionals Only </div>
            
            <div class='optional-cta'><a href="https://www.vaccineshoppe.com/index.cfm?fa=anon.guidedSearch&amp;N=0&amp;Ntk=All&amp;Ntt=589-05" target="_blank">Order Menactra Now</a></div>
        </div>
    </div>
    <nav class="navbar navbar-expand-lg navbar-light">
        <div class='audience-company-mobile'>
            <div class='audience-statement-small audience'>For US Healthcare Professionals Only </div>
            <div class='company-small'><a href='https://www.sanofi.us/'><img src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/sanofi-pasteur-logo.png?h=52&amp;la=en&amp;w=312&amp;hash=675D044D0BBDC7C416DE33DC1A3C2FEB0E83B1A7" alt="Sanofi Pasteur logo" width="312" height="52" /></a></div>
        </div>
        <a class="navbar-brand brand-small" href="/"><img src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/logo.png?h=269&amp;la=en&amp;w=589&amp;hash=7BD02259D1233F8074728710046F6706B935C7CE" alt="MenactraВ® (Groups A,C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine logo" width="589" height="269" /></a>
        <button class="navbar-toggler collapsed" type="button" data-toggle="collapse" data-target="#navbarNavDropdown"
            aria-controls="navbarNavDropdown" aria-expanded="false" aria-label="Toggle navigation">
            <div class='menu-text'></div>
        </button>
        <div class='optional-cta-mobile'><a href="https://www.vaccineshoppe.com/index.cfm?fa=anon.guidedSearch&amp;N=0&amp;Ntk=All&amp;Ntt=589-05" target="_blank">Order Menactra Now</a> <span></span></div>
        <div class="collapse navbar-collapse" id="navbarNavDropdown">
            <div id='search-small'><input id='search-field' type='text' placeholder='SEARCH' /><button
                    id='perform-search'></button></div>
            

<ul  class="nav navbar-nav"><li  class="score-megamenu-basic-item"><a href="#are-you-teens-protected" class="menuone">ARE YOUR TEENS PROTECTED? </a></li><li  class="score-megamenu-basic-item"><a href="#about-menctra">ABOUT MENACTRA </a></li></ul>
        </div>
        <div class='utility-links-small'>
            <div class='nav-items'>
                <div class='nav-item'><a href="#in-page-isi" class="hcpone">Important <br>Safety Information</a></div>
                <div class='nav-item'><a href="https://www.vaccineshoppe.com/image.cfm?doc_id=12580&amp;image_type=product_pdf" class="hcptwo" target="_blank">Prescribing<br> Information</a></div>
                <div class='nav-item'><a href="https://www.sanofiusmedicalinformation.com/" class="hcp-link" target="_blank">Medical<br> Information</a></div>
            </div>
        </div>
    </nav>
    <script>
        (function () {
            if ('1' === '1') {
                var scripts = document.getElementsByTagName("script");
                var thisScript = scripts[scripts.length - 1];
                thisScript.parentNode.classList.add('nav2');
            }
        })();

    </script>
</header></div><div  class="row one-column">        <div class="col-lg-12">
            
        </div>
</div>
        </div>
</div>
    </div>
    <div class="container">
        <div  id="are-you-teens-protected" class="row one-column are-you-teens-protected">        <div class="col-lg-12">
            
<div ><div class="dcv-hero-container">
    <style>
        .hero-img {
            background-image: url('https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/drummer-girl_new.png');
        }

        
        @media screen and (max-width: 767px) {
            .hero-img {
                background-image: url('https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/drum-girl-mobile_new.png');
            }
        }
        

        

        
    </style>
    <div class="row hero-img">
        <div class="hero-copy">
            <h1><p class="top">SHEвЂ™S OUTGROWN
<br> HER FIRST DOSE</p></h1>
            <p><p class="subhead">IT&rsquo;S TIME FOR ANOTHER</p>
<p><strong>Are your patients protected from meningococcal disease?<sup>1-4</sup></strong></p>
<ul class="list">
    <li style="padding-bottom:10px;"><strong>ACIP<sup>a</sup> recommends 16-year-old adolescents receive a 2nd dose of MenACWY<sup>b</sup></strong></li>
    <li><strong>About half of adolescents in the US may be at risk</strong> of contracting meningococcal disease&nbsp;because they have missed their 2nd dose of MenACWY </li>
</ul>
<p class="body"><strong>Menactra is indicated for active immunization to prevent invasive meningococcal disease caused by <em>Neisseria meningitidis</em> serogroups A, C, Y, and W-135. Menactra is approved for use in individuals 9&nbsp;months through 55&nbsp;years of age. Menactra does not prevent <em>N&nbsp;meningitidis</em> serogroup B disease.<sup>5</sup></strong></p>
<p class="body"><strong>A single booster dose of Menactra </strong>may be given to individuals <nobr>15-55 years</nobr> of&nbsp;age at continued risk for meningococcal disease if at least 4 years have elapsed since the prior dose.<sup>5</sup></p>
<p class="body"><strong>The most common local and systemic adverse reactions</strong> to Menactra include pain, redness, and swelling at the injection site and appetite loss (all&nbsp;age groups); induration at the injection site and diarrhea (all age groups except infants); irritability and drowsiness (infants and children); abnormal crying, vomiting, and fever (infants); headache, fatigue, malaise, and arthralgia (adolescents and adults).<sup>5</sup>
</p></p>

            
            <div class="hero-button">
                <a href="https://www.vaccineshoppe.com/index.cfm?fa=anon.guidedSearch&amp;N=0&amp;Ntk=All&amp;Ntt=589-05" title="Menactra order information" target="_blank">Order Menactra</a>
            </div>
            
        </div>
        <div class="disclaimer"><div class="foot">
</div>
<div class="scr">
<a href="#about-menctra"></a>
<p><a href="#about-menctra" style="color:#fff!important;">SCROLL DOWN</a></p>
<a href="#about-menctra">
<img alt="" src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/scroll-down-arrow.png?la=en&amp;hash=C1645355F221A7401EF87DCB36C32637B4B98914" width="14" height="12">
</a></div></div>
    </div>
</div></div>
        </div>
</div><div  id="about-menctra" class="row one-column about-menctra">        <div class="col-lg-12">
            
<div >
<style>
@media screen and (min-width:320px) and (max-width:767px) {
.hero{
    
        background-image: url('https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/skater-man-mobile.png');
    
        
}
}

@media screen and (min-width: 768px) and (max-width:991px){
   .hero{
       
            background-image: url('https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/skater-boy.png');
        
}

}

@media screen and (min-width: 992px) and (max-width: 1024px) {
   .hero{
     
        background-image: url('https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/skater-boy.png');
    
}


}

@media screen and (min-width: 1025px){
   .hero{
    background-image: url('https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/skater-boy.png');
}

}
</style>
<div class="hero-container">
<div class="row hero">
    <div class="hero-copy">
        <h1><p class="sub">ITвЂ™S TIME FOR A 2<sup>ND</sup> DOSE </p></h1>
        <p><div class="body">
<p class="subheading" style="display:initial;">SINCE 2005</p>
<ul style="margin-top:10px;">
    <li>Menactra was first licensed in 2005 and received FDA approval to be administered as a 2nd dose to adolescents and adults in 2014<sup>5,6</sup></li>
</ul>
<p><span style="font-weight: bold; font-family: arial; font-size: 16px;">PRIMARY VACCINATION:</span></p>
<ul>
    <li>In children 9 through 23 months of age, Menactra is given as a 2-dose series, <br class="desktop-only">
    3 months apart<sup>5</sup></li>
    <li>In individuals 2 through 55 years of age, Menactra is given as a single dose<sup>5</sup></li>
</ul>
<p><span style="font-weight: bold; font-family: arial; font-size: 16px;">BOOSTER VACCINATION:</span></p>
<ul>
    <li>A single booster dose of Menactra may be given to individuals 15 through <br class="desktop-only">
    55 years of age at continued risk for meningococcal disease if at least <br class="desktop-only">
    4 years have elapsed since the prior dose<sup>5</sup></li>
</ul>
<p class="subheading">IMMUNOGENICITY</p>
<ul>
    <li>A 2nd dose of Menactra induced <br class="mobile-only">
    protective titer levels in more <br class="mobile-only">
    than <strong> <br class="desktop-only">
    99% of trial participants<sup>5,7</sup></strong>
    </li>
</ul>
<p class="study-design-copy" style="color:#00539f; font-family: arial; padding:10px 0 10px 0;">2nd Dose Immunogenicity in Adolescents <br class="mobile-only">
and Adults</p>
<p style="padding-bottom:0px; margin-bottom:0px;"><img alt="Immunogenicity 2nd dose chart" src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/graph.png?h=379&amp;w=400&amp;la=en&amp;hash=9CB108F7D78B83194CEBA60F567D4D63905EAA99" style="width: 150%; max-width:400px;"></p>
<p class="study-design-copy" style="max-width:77%; margin-bottom:3rem;"><strong>Study Design: </strong>A phase 2, open-label study was conducted between September 2011 and July 2012 at 15 centers <br class="desktop-only">
in the US that evaluated the safety and immunogenicity of a single booster dose of Menactra at 4 to 6 years after <br class="desktop-only">
prior vaccination in persons first vaccinated at 11 through 55 years of age. A total of 834 participants were enrolled; <br class="desktop-only">
of these, 781 met criteria for inclusion in the per-protocol population for the immunogenicity analysis.<sup>5</sup></p>
<p class="subheaddown" style="display:initial;">SAFETY</p>
<p class="margin-top-8-2" style="margin-bottom:0;"><span style="font-weight: bold; font-family: arial; font-size: 16px;">FIRST DOSE:</span></p>
<ul style="max-width:90%;">
    <li>The most common solicited injection site and systemic adverse reactions within 7 days after a single dose of Menactra in adolescents aged 11 to 18 years were injection site pain (59.2%), headache (35.6%), and fatigue (30%)<sup>5</sup></li>
</ul>
<p><span style="font-weight: bold; font-family: arial; font-size: 16px;">SECOND DOSE:</span></p>
<ul style="max-width:90%;">
    <li>The most common solicited injection site and systemic adverse reactions within 7 days after a second dose of Menactra in adolescents and adults were pain (60.2%) and myalgia (42.8%)<sup>5</sup></li>
</ul>
<p class="subheaddown">
NO RECONSTITUTION REQUIRED
</p>
</div></p>
<!--    mobile view content only start 
-->       <!--<div class="footnote text-right d-block d-md-none"></div>-->
<!--         mobile view content only end 
-->        
    </div>
<div class="footnote text-right"></div>
</div>
</div>
</div>
        </div>
</div>
    </div>
    <div class="container">
        <div  class="row one-column">        <div class="col-lg-12">
            
<div ><footer id='in-page-isi' class='in-page-isi'>
    <div class='brand-desc'>
        
    </div>
    <div class='isi-body'>
        <h4>IMPORTANT SAFETY INFORMATION <br class="hide-tag-m">
FOR MENACTRA </h4>
<p>Menactra is contraindicated in persons who have had a severe allergic reaction (eg, anaphylaxis) after a previous dose of a meningococcal capsular polysaccharide-, diphtheria toxoid-, or CRM<sub>197</sub>-containing vaccine, or to any component of the vaccine.</p>
<p>Persons previously diagnosed with Guillain-Barr&eacute; syndrome (GBS) may be at increased risk of GBS following receipt of Menactra. GBS has been reported in temporal relationship following administration of Menactra. The decision to give Menactra should be based on careful consideration of the potential benefits and risks. </p>
<p>Syncope (fainting) can occur in association with administration of injectable vaccines, including Menactra. Procedures should be in place to prevent falling injury and manage syncopal reactions.</p>
<p>The most common local and systemic adverse reactions to Menactra include pain, redness, and swelling at the injection site and appetite loss (all age groups); induration at the injection site and diarrhea (all age groups except infants); irritability and drowsiness (infants and children); abnormal crying, vomiting, and fever (infants); headache, fatigue, malaise, and arthralgia (adolescents and adults). Other adverse reactions may occur. Vaccination with Menactra may not protect all individuals. </p>
<p id="PI_link" style="padding-bottom:5px;"><strong>Before administration, please see the full <a href="https://www.vaccineshoppe.com/image.cfm?doc_id=12580&image_type=product_pdf" target=" _blank">Prescribing Information</a> for Menactra. </strong></p>
<p><strong><a href="http://products.sanofi.us/Resources/US_COR_14_05_008_Counterfeit_Brochure.pdf" target=" _blank">Click here</a> to learn more about Sanofi's commitment to fighting counterfeit drugs. </strong></p>
<br>
<ul class="ul-ref">
    <li>ACIP = Advisory Committee on Immunization Practices.</li>
    <li>MenACWY = Quadrivalent (serogroups A, C, W, and Y) meningococcal conjugate vaccine.</li>
    <li>hSBA = Serum bactericidal assay using human complement.</li>
    <li>hSBA antibody titers &ge;1:8 are considered protective against invasive meningococcal disease.</li>
</ul>
<br>
<p><strong>References:</strong> <strong>1. </strong>Centers for Disease Control and Prevention (CDC). Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2020. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Accessed April 15, 2020. <strong>2.</strong> CDC. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger&mdash;United States, 2017. <em>MMWR.</em> 2017;66(5):134-135. <strong>3.</strong> CDC Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). <em>MMWR</em>. 2013;62(RR-2):1-28.
<strong>4. </strong>Walker TY, Elam-Evans LD, Yankey D, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years&mdash;United States, 2018. <em>MMWR</em>. 2019;68(33):718-723. <strong>5. </strong>Menactra vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.<strong> 6.</strong> Federal Drug Administration. September 4, 2014 approval letter - Menactra [letter]. September 4, 2014. http://wayback.archive-it.org/7993/20170723032500/https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm413177.htm. Accessed April 15, 2020.<string> <strong>7.</strong> Robertson CA, Greenberg DP, Hedrick J. Pichichero M, Decker MD, Saunders M. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W and Y) polysaccharide diphtheria toxoid conjugate vaccine.<em> Vaccine.</em> 2016;34(44):5273-5278. </string></p>
    </div>
    <div class='isi-aside'>
        <p></p>
    </div>
    
    <div class='isi-footnote'>
        <p><sup>*</sup></p>
    </div>
    <div class='back-to-top'><span>Back to the top &#9650;</span></div>
    <div class="references-isi">
        
    </div>
    <div class='info'>
        <p><a href="https://www.sanofipasteur.com/" target="_blank"><img alt="Sanofi Pasteur logo" src="https://www.menactra.com:443/-/media/EMS/Conditions/Vaccines/Brands/Menactra-HCP/sanofi-pasteur-logo.png?la=en&amp;hash=89AD88F0169A5B62DC605CDD06376B829550302A"></a>
<p>&copy; 2020 Sanofi Pasteur Inc.</p></p>
        <p><a href="http://www.vaccineplace.com/privacypolicy/terms.html" class="vaccineclass" target="_blank">Legal Disclaimer </a> 
        
            | <a href="http://www.vaccineplace.com/privacypolicy/privacypolicy.html" class="privacyclass" target="_blank">Privacy Policy </a> 
         
         
            | <a href="https://www.sanofipasteur.com/en/contact" class="contactclass" target="_blank">Contact us</a></p>
        
        <p><b>This site is intended for use by US Healthcare Professionals only.</b></p>
        <p><span>MAT-US-2005494<br/></span> Last Updated: 06/20</p>
        
    </div>
    <div class="modal fade" id="interstitial-modal" role="dialog" aria-hidden="true">
        <div class="modal-dialog" role="document">
            <div class="modal-content">
                <div class="modal-header">
                    <div><h3>You are about to leave.</h3></div>
                </div>
                <div class="modal-body">
                    <p>Do you wish to continue?</p>
                </div>
                <div class="modal-footer">
                    <a id='interstitial-cancel' href='#' class="btn btn-secondary" data-dismiss="modal">Cancel</a>
                    <a id='interstitial-confirm' class="btn btn-confirm">Continue</a>
                </div>
            </div>
        </div>
    </div>
    <div class="modal fade" id="hcp-modal" role="dialog" aria-hidden="true">
        <div class="modal-dialog" role="document">
            <div class="modal-content">
                <div class="modal-header">
                    <div><h3>This site is intended for healthcare professionals.</h3></div>
                </div>
                <div class="modal-body">
                    <p>Do you wish to continue?</p>
                </div>
                <div class="modal-footer">
                    <a id='hcp-cancel' href='#' class="btn btn-secondary" data-dismiss="modal">Close</a>
                    <a id='hcp-confirm' class="btn btn-confirm">Continue</a>
                </div>
            </div>
        </div>
    </div>
    <div class='fixed-isi'>
        <div>
            <div>
                <h4>IMPORTANT SAFETY INFORMATION FOR MENACTRA</h4>
<p>Menactra is contraindicated in persons who have had a severe allergic reaction (eg, anaphylaxis) after a previous dose of a meningococcal capsular polysaccharide-, diphtheria toxoid-, or CRM<sub>197</sub>-containing vaccine, or to any component of the vaccine.</p>
<p>Persons previously diagnosed with Guillain-Barr&eacute; syndrome (GBS) may be at increased risk of GBS following receipt of Menactra. GBS has been reported in temporal relationship following administration of Menactra. The decision to give Menactra should be based on careful consideration of the potential benefits and risks.</p>
            </div>
            <div class='expand-plus'></div>
        </div>
    </div>
</footer></div><div  class="row one-column">        <div class="col-lg-12">
            

        </div>
</div>
        </div>
</div>
    </div>


    <!-- Adding jquery from CDN -->
    <![if gte IE 9]>
    
    <![endif]>
    <!--[if lte IE 8]>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/1.8.3/jquery.min.js"></script>
    <![endif]-->



    <script src=/Areas/GlobalComponents/js/Global/Libraries/Bootstrap/popper.min.js></script>
    <script src=/Areas/GlobalComponents/js/Global/Libraries/Bootstrap/bootstrap.min.js></script>
    <script src=/Areas/GlobalComponents/js/Global/Libraries/FontAwesome/all-5.4.2.min.js></script>
     
    

    <script src="/resources/js/site/8e6f5b54f06840e8856e18264d4053f8.js?u=20200529041703"></script>



    <script language="javascript" type="text/javascript">
        $.ajaxPrefilter(function (options) {
            if (options.url === "/api/DynamicForm/SendFormData") {
                var FormID = JSON.parse(decodeURIComponent(options.data)).FormID;
                if (FormID != undefined) {
                    console.log('options form ID - ' + FormID); 
                    if ($('#RequestTokenID-' + FormID).length) {
                        var token = $('#RequestTokenID-' + FormID).val();
                        options.beforeSend = function (xhr) {
                            xhr.setRequestHeader('FormSubmissionVerificationToken', token);
                        }
                    }
                }
            }
        });
    </script>


<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="5583FD6A22724816BD9CC2C6453CBE77">
</body>
</html>
